Research on Antiemetic-Antivertigo Agents Described by a Researcher at Ben-Gurion University of the Negev (Ondansetron Use During Pregnancy: Birth Defects and Obstetric Outcomes).

Předmět:	ONDANSETRON HUMAN abnormalities PREGNANCY SMALL for gestational age
Zdroj:	Women's Health Weekly; 3/31/2023, p1907-1907, 1p
Abstrakt:	Keywords: 5ht3 Receptor Antagonists; Antiemetic-Antivertigo Agents; Central Nervous System Agents; Drugs and Therapies; Health and Medicine; Obstetrics; Ondansetron Therapy; Pharmaceuticals; Women's Health EN 5ht3 Receptor Antagonists Antiemetic-Antivertigo Agents Central Nervous System Agents Drugs and Therapies Health and Medicine Obstetrics Ondansetron Therapy Pharmaceuticals Women's Health 1907 1907 1 03/27/23 20230331 NES 230331 2023 MAR 31 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Data detailed on antiemetic-antivertigo agents have been presented. 5ht3 Receptor Antagonists, Antiemetic-Antivertigo Agents, Central Nervous System Agents, Drugs and Therapies, Health and Medicine, Obstetrics, Ondansetron Therapy, Pharmaceuticals, Women's Health. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu